Bor-Yu Tsai

Title: Bor-Yu Tsai: Innovator in Cancer Immunotherapy

Introduction

Bor-Yu Tsai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer immunotherapy, holding a total of 3 patents. His work focuses on developing innovative solutions for cancer diagnosis and treatment.

Latest Patents

One of his latest patents is the "Anti-carbonic anhydrase IX antibody." This invention relates to epitopes located in CAIX and anti-CAIX antibodies that exhibit binding activity with cancer cells. The patent also covers the composition and application of CAIX epitopes and anti-CAIX antibodies in the diagnosis, prevention, and treatment of cancers. Another notable patent is for "Personalized cancer immunotherapy." This disclosure outlines a method for obtaining an antibody or antigen-binding fragment that specifically binds to a tumor sample. The process involves administering autologous dendritic cells to a subject, taking immune cells and a tumor sample, constructing an antibody library, and screening it to obtain the specific antibody.

Career Highlights

Bor-Yu Tsai has worked with companies such as Navi Bio-Therapeutics, Inc. and Navi Bio-Therapeutics, Inc. His innovative approaches have positioned him as a key figure in the development of cancer therapies.

Collaborations

Some of his notable coworkers include Wei-Ting Hsu and Shin-Tsung Huang, who have collaborated with him on various projects in the field of cancer research.

Conclusion

Bor-Yu Tsai's contributions to cancer immunotherapy through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer treatment and diagnosis.